product Name：Ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepine-3-carboxylate
  • Ethyl loflazepate [INN:JAN]; Ethyl loflazepate; 5-25-08-00124 (Beilstein Handbook Reference); BRN 0765264; CM 6912; Ethyl fluclozepate; Ethylis loflazepas; Ethylis loflazepas [INN-Latin]; Loflazepate d'ethyle; Loflazepate d'ethyle [INN-French]; Loflazepato de etilo; Loflazepato de etilo [INN-Spanish]; Loflazepic acid, ethyl ester; UNII-VJB5FW9W9J; Victan; 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-oxo-, ethyl ester; DEA No. 2758; ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepine-3-carboxylate
  • 29177-84-2
  • 249-489-4
  • C18H14ClFN2O3
  • 360.7668
  • InChI=1/C18H14ClFN2O3/c1-2-25-18(24)16-17(23)21-14-8-7-10(19)9-12(14)15(22-16)11-5-3-4-6-13(11)20/h3-9,16H,2H2,1H3,(H,21,23)
  • Ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepine-3-carboxylate 29177-84-2
  • 1.39g/cm3
  • 507.7°C at 760 mmHg
  • 1.624
  • 260.9°C
  • 1.98E-10mmHg at 25°C